Glycyrrhizic acid increased FMD vaccine potency in a mineral-based adjuvant, but not in an oil-based adjuvant
Acta Veterinaria Hungarica · 2026
DOI: 10.1556/004.2026.01269 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Veterinaria Hungarica, 2026. Verfasst von Sara Ghasemkhani und 10 weiteren Autor:innen. Beteiligte Einrichtung: 1Department of Microbiology, NT.C., Islamic Azad University, Tehran, Iran. Hauptthemen laut MEDLINE: Glycyrrhizic Acid, Adjuvants, Immunologic, Viral Vaccines, Adjuvants, Vaccine. Die Arbeit nennt 31 Literaturangaben.
Abstract (Originalsprache)
Inactivated FMD vaccine with aluminium hydroxide induces Th2 response. Glycyrrhizin is a triterpenoid saponin extracted from the licorice plant, which has immunomodulatory activities. In this study, two different formulations (oil- and alum-based adjuvants) of FMD vaccines were used to see if glycyrrhizic acid (GZA) has an enhancing effect on the adjuvant, and whether its impact depends on the nature of the co-administered adjuvant or not. Balb/c mice were immunised subcutaneously on days 0, 14, and 28 with 2 μg of inactivated FMD virus formulated in Alum or Montanide ISA206 adjuvant with or without GZA. Two weeks later, IFN-γ, IL-2 and IL-4 cytokines, specific total IgG antibodies, IgG1 and IgG2a isotypes, IgG avidity index and serum neutralisation activity were evaluated. The results indicate that GZA enhanced IFN-γ, IL-2 and IFN-γ/IL-4 levels and specific IgG titre compared to the FMD-Alum group. In addition, FMD-Montanide ISA206-GZA enhanced IFN-γ and IFN-γ/IL-4 ratio, whereas it suppressed the specific IgG titre and the avidity index. Furthermore, serum neutralisation tests showed a significant increase in FMD-Alum-GZA group, while GZA in the Montanide-based vaccine suppressed the serum neutralisation response. These findings suggest that the adjuvant effect of GZA is dependent on the co-administered adjuvant.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- 1Department of Microbiology, NT.C., Islamic Azad University, Tehran, Iran.
- 2Department of BCG Vaccine Production, Production and Research Complex, Pasteur Institute of Iran, Karaj, Iran.
- 3Department of FMD Vaccine Production, Razi Vaccine & Serum Research Institute, Agricultural Research, Education & Extension Organization (AREEO), Karaj, Iran.
- 4Department of Pharmaceutical Biotechnology, Faculty of Pharmacy and Biotechnology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
- 5Department of Pharmacognosy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
- 6Department of Biotechnology, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran.
ORCID-Profile: Fatemeh Ashrafi, Mehdi Mahdavi
Zitieren
APA
Ghasemkhani, S., Ashrafi, F., Hassanzadeh, S. M., Khorasani, A., Feizabadi, H., Sanaye-Pasand, M. R., Delnavazi, M. R., Ghayoumian, M., Yazdi, M. H., Taghizadeh, M., & Mahdavi, M. (2026). Glycyrrhizic acid increased FMD vaccine potency in a mineral-based adjuvant, but not in an oil-based adjuvant. Acta Veterinaria Hungarica. https://doi.org/10.1556/004.2026.01269
Vancouver
Ghasemkhani S, Ashrafi F, Hassanzadeh SM, Khorasani A, Feizabadi H, Sanaye-Pasand MR, et al. Glycyrrhizic acid increased FMD vaccine potency in a mineral-based adjuvant, but not in an oil-based adjuvant. Acta Veterinaria Hungarica. 2026. doi:10.1556/004.2026.01269
BibTeX
@article{Ghasemkhani2026,
author = {Ghasemkhani, Sara and Ashrafi, Fatemeh and Hassanzadeh, Seyed Mehdi and Khorasani, Akbar and Feizabadi, Hossein and Sanaye-Pasand, Mohammad-Reza and Delnavazi, Mohammad Reza and Ghayoumian, Marziyeh and Yazdi, Mohammad Hossein and Taghizadeh, Morteza and Mahdavi, Mehdi},
title = {Glycyrrhizic acid increased FMD vaccine potency in a mineral-based adjuvant, but not in an oil-based adjuvant},
journal = {Acta Veterinaria Hungarica},
year = {2026},
doi = {10.1556/004.2026.01269}
}
EUVIMED